These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 38387622)
1. The hepatocyte growth factor mimetic, ANG-3777, in kidney transplant recipients with delayed graft function: Results from a randomized phase 3 trial. Vincenti F; Bromberg J; Kim J; Faravardeh A; Leca N; Alperovich G; Csomor PA; Aslam S; Neylan J Am J Transplant; 2024 Feb; ():. PubMed ID: 38387622 [TBL] [Abstract][Full Text] [Related]
2. Phase 3 trial Design of the Hepatocyte Growth Factor Mimetic ANG-3777 in Renal Transplant Recipients With Delayed Graft Function. Vincenti F; Kim J; Gouveia D; Pelle G; Mayne TJ; Neylan JF Kidney Int Rep; 2021 Feb; 6(2):296-303. PubMed ID: 33615054 [TBL] [Abstract][Full Text] [Related]
3. Renal Function Improvement Following ANG-3777 Treatment in Patients at High Risk for Delayed Graft Function After Kidney Transplantation. Bromberg JS; Weir MR; Gaber AO; Yamin MA; Goldberg ID; Mayne TJ; Cal W; Cooper M Transplantation; 2021 Feb; 105(2):443-450. PubMed ID: 32265417 [TBL] [Abstract][Full Text] [Related]
4. Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients. Huang E; Vo A; Choi J; Ammerman N; Lim K; Sethi S; Kim I; Kumar S; Najjar R; Peng A; Jordan SC Clin J Am Soc Nephrol; 2020 Jan; 15(1):109-116. PubMed ID: 31843975 [TBL] [Abstract][Full Text] [Related]
5. A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients. Jordan SC; Choi J; Aubert O; Haas M; Loupy A; Huang E; Peng A; Kim I; Louie S; Ammerman N; Najjar R; Puliyanda D; Vo A Am J Transplant; 2018 Dec; 18(12):2955-2964. PubMed ID: 29637714 [TBL] [Abstract][Full Text] [Related]
6. Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation. Collins MG; Fahim MA; Pascoe EM; Dansie KB; Hawley CM; Clayton PA; Howard K; Johnson DW; McArthur CJ; McConnochie RC; Mount PF; Reidlinger D; Robison L; Varghese J; Vergara LA; Weinberg L; Chadban SJ; Trials; 2020 May; 21(1):428. PubMed ID: 32450917 [TBL] [Abstract][Full Text] [Related]
8. Effect of Perioperative Dexmedetomidine on Delayed Graft Function Following a Donation-After-Cardiac-Death Kidney Transplant: A Randomized Clinical Trial. Shan XS; Hu LK; Wang Y; Liu HY; Chen J; Meng XW; Pu JX; Huang YH; Hou JQ; Feng XM; Liu H; Meng L; Peng K; Ji FH JAMA Netw Open; 2022 Jun; 5(6):e2215217. PubMed ID: 35657627 [TBL] [Abstract][Full Text] [Related]
9. Protective Effects of L-Carnitine Against Delayed Graft Function in Kidney Transplant Recipients: A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Jafari A; Khatami MR; Dashti-Khavidaki S; Lessan-Pezeshki M; Abdollahi A; Moghaddas A J Ren Nutr; 2017 Mar; 27(2):113-126. PubMed ID: 28065453 [TBL] [Abstract][Full Text] [Related]
11. Statistical analysis plan for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a randomised controlled trial of the effect of intravenous fluid therapy with balanced crystalloid versus saline on the incidence of delayed graft function in deceased donor kidney transplantation. Pascoe EM; Chadban SJ; Fahim MA; Hawley CM; Johnson DW; Collins MG; Trials; 2022 Jan; 23(1):52. PubMed ID: 35042554 [TBL] [Abstract][Full Text] [Related]
12. Peri-transplant aminophylline in pediatric kidney transplant recipients of donation after brain death: a double-blinded placebo-controlled randomized clinical trial. Haskin O; Shih W; Wong CJ; Axelrod DM; Grimm PC Pediatr Nephrol; 2020 Sep; 35(9):1729-1736. PubMed ID: 32418145 [TBL] [Abstract][Full Text] [Related]
13. Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation. Bumgardner GL; Hardie I; Johnson RW; Lin A; Nashan B; Pescovitz MD; Ramos E; Vincenti F; Transplantation; 2001 Sep; 72(5):839-45. PubMed ID: 11571447 [TBL] [Abstract][Full Text] [Related]
14. Effect of hemodialysis before transplant surgery on renal allograft function--a pair of randomized controlled trials. Kikić Z; Lorenz M; Sunder-Plassmann G; Schillinger M; Regele H; Györi G; Mühlbacher F; Winkelmayer WC; Böhmig GA Transplantation; 2009 Dec; 88(12):1377-85. PubMed ID: 20029334 [TBL] [Abstract][Full Text] [Related]